Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study.
Kang W, Kim YJ, Kim SU, Seo YS, Kim JW, Kim JH, Park SY, Baek YH, Kim KM, Lee HL, Yoon KT, Kim H, Cheong JY, Hwang JS, Kim JH, Kim KM, Sung PS, Kim J, Kim DY.
Kang W, et al. Among authors: kim yj.
Future Oncol. 2024 Sep 25:1-11. doi: 10.1080/14796694.2024.2397328. Online ahead of print.
Future Oncol. 2024.
PMID: 39320906